Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -436,373 | -479,449 | -654,588 | -384,770 | -246,283 |
| Depreciation Amortization | 38,194 | 31,904 | 43,126 | 37,684 | 24,810 |
| Accounts receivable | -21,389 | 8,378 | 375 | -44,353 | -5,463 |
| Accounts payable and accrued liabilities | -2,820 | 5,191 | 60,328 | 34,796 | 505 |
| Other Working Capital | -60,862 | 53,840 | 61,564 | -40,468 | -47,665 |
| Other Operating Activity | 243,392 | 55,161 | 179,732 | 188,094 | 170,169 |
| Operating Cash Flow | $-239,858 | $-324,975 | $-309,463 | $-209,017 | $-103,927 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -226,223 | 860,736 | 227,277 | 11,880 | -563,027 |
| PPE Investments | -35,085 | -20,486 | -77,461 | -75,035 | -36,173 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -17,886 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -17,886 |
| Investing Cash Flow | $-261,308 | $840,250 | $149,816 | $-63,155 | $-617,086 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,132,750 |
| Debt Repayment | N/A | N/A | N/A | N/A | -174 |
| Common Stock Issued | 14,838 | 503,675 | 11,941 | 17,865 | 371,223 |
| Other Financing Activity | -15,834 | -26,300 | -201,034 | -84,689 | -93,492 |
| Financing Cash Flow | $-996 | $477,375 | $-189,093 | $-66,824 | $1,410,307 |
| Exchange Rate Effect | -1,770 | -911 | -1,600 | -1,693 | 455 |
| Beginning Cash Position | 1,133,687 | 141,948 | 492,288 | 832,977 | 143,228 |
| End Cash Position | 629,755 | 1,133,687 | 141,948 | 492,288 | 832,977 |
| Net Cash Flow | $-503,932 | $991,739 | $-350,340 | $-340,689 | $689,749 |
| Free Cash Flow | |||||
| Operating Cash Flow | -239,858 | -324,975 | -309,463 | -209,017 | -103,927 |
| Capital Expenditure | -35,085 | -20,486 | -77,461 | -75,035 | -36,173 |
| Free Cash Flow | -274,943 | -345,461 | -386,924 | -284,052 | -140,100 |